-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
-
Summary
-
Lexicon Pharmaceuticals, Inc. annual/quarterly Cash and Cash Equivalents, Period Increase (Decrease) history and growth rate from Q1 2011 to Q1 2022.
- Lexicon Pharmaceuticals, Inc. Cash and Cash Equivalents, Period Increase (Decrease) for the quarter ending March 31, 2022 was -$4.55M, a 84.1% increase year-over-year.
- Lexicon Pharmaceuticals, Inc. annual Cash and Cash Equivalents, Period Increase (Decrease) for 2022 was -$17.7M, a 71.5% increase from 2021.
- Lexicon Pharmaceuticals, Inc. annual Cash and Cash Equivalents, Period Increase (Decrease) for 2021 was -$62.2M, a 169% decline from 2020.
- Lexicon Pharmaceuticals, Inc. annual Cash and Cash Equivalents, Period Increase (Decrease) for 2020 was $90.2M.
Cash and Cash Equivalents, Period Increase (Decrease), Quarterly (USD)
Cash and Cash Equivalents, Period Increase (Decrease), YoY Quarterly Growth (%)